<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.napwa.org.au" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>bevirimat (MPC-4326, PA-457)</title>
 <link>http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment</link>
 <description>Customised to include nested data</description>
 <language>en-au</language>
<item>
 <title>AIDS 2008: Is the HIV drug pipeline drying up?</title>
 <link>http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up</link>
 <description> &lt;p&gt;The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-&lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistant&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt; HIV, all of which are now available in Australia.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <enclosure url="http://www.napwa.org.au/image/view/868/preview" length="16012" type="image/jpeg" />
 <pubDate>Tue, 23 Sep 2008 19:21:56 -0700</pubDate>
 <dc:creator>David Menadue</dc:creator>
 <guid isPermaLink="false">869 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>News and treatments briefs</title>
 <link>http://www.napwa.org.au/pl/2007/03/news-and-treatments-briefs</link>
 <description> &lt;p&gt;HIV-related news in brief from the March 2007 edition of &lt;cite&gt;Positive Living&lt;/cite&gt;.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2007/03/news-and-treatments-briefs&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/complementary-and-alternative-therapies">complementary and alternative therapies</category>
 <category domain="http://www.napwa.org.au/living-with-hiv/sex-and-relationships/disclosure">disclosure</category>
 <category domain="http://www.napwa.org.au/treating-hiv/healthy-living/nutrition">nutrition</category>
 <category domain="http://www.napwa.org.au/defeating-hiv/hiv-prevention/preventative-vaccines">preventative vaccines</category>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <pubDate>Wed, 21 Mar 2007 07:06:27 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">615 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Looking forward, looking back</title>
 <link>http://www.napwa.org.au/pl/2006/06/looking-forward-looking-back</link>
 <description> &lt;p&gt;In September 2006, the International Association of Physicians in AIDS Care will mark a decade of highly active &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/122&quot;&gt;&lt;span&gt;antiretroviral&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A medication or other substance which is active against retroviruses such as HIV.&lt;/span&gt; therapy. Has it really been 10 years since the so-called Protease Moment? KIRSTY MACHON reports on where we have come from &amp;ndash; and where to from here.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2006/06/looking-forward-looking-back&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors">entry and fusion inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/integrase-inhibitors">integrase inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/maturation-inhibitors">maturation inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/multi-class-formulations">multi-class formulations</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/experimental-treatments">experimental treatments</category>
 <enclosure url="http://www.napwa.org.au/image/view/839/preview" length="8280" type="image/jpeg" />
 <pubDate>Wed, 12 Jul 2006 07:08:19 -0700</pubDate>
 <dc:creator />
 <guid isPermaLink="false">572 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>The bleeding edge</title>
 <link>http://www.napwa.org.au/pl/2005/04/the-bleeding-edge</link>
 <description> &lt;p&gt;The annual Retrovirus Conference is a key event on the HIV scientific calendar, and regularly highlights  the most exciting &amp;lsquo;bleeding edge&amp;rsquo; developments from the world of HIV science.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2005/04/the-bleeding-edge&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-1">aplaviroc (GSK-873,140)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/346">conference reports</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/diabetes">diabetes</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/heart-disease">heart disease</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy/treatment">polylactic acid</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/sexually-transmissible-infections">sexually-transmissible infections</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-0">TAK-652</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/treatment-side-effects">treatment side effects</category>
 <enclosure url="http://www.napwa.org.au/image/view/820/preview" length="52180" type="image/jpeg" />
 <pubDate>Wed, 18 May 2005 07:00:25 -0700</pubDate>
 <dc:creator>John Daye</dc:creator>
 <guid isPermaLink="false">149 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Bangkok AIDS Conference: Small steps</title>
 <link>http://www.napwa.org.au/pl/2004/08/bangkok-aids-conference-small-steps</link>
 <description> &lt;p&gt;There isn&amp;rsquo;t a lot of Earth-shattering news to report from Bangkok, but as always there were numerous small developments. As PAUL KIDD explains, some of these small steps could develop into giant leaps.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2004/08/bangkok-aids-conference-small-steps&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/346">conference reports</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors/t-20">enfuvirtide (T-20)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/fosamprenavir">fosamprenavir/amprenavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/maturation-inhibitors">maturation inhibitors</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/235">Thailand</category>
 <enclosure url="http://www.napwa.org.au/image/view/848/preview" length="39053" type="image/jpeg" />
 <pubDate>Sat, 14 Aug 2004 13:00:22 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">83 at http://www.napwa.org.au</guid>
</item>
</channel>
</rss>

